Search
The majority of the U.S. Congress took no action at all in 2014 in favor of holding corporations accountable and reining in corporate power - scoring a zero on the newly released Corporate Accountability Coalition (CAC) Congressional Report Card.
Tennessee Sen. Bill Frist has been ferried on corporate aircraft more than most other politicians in Washington over the past five years, according to a study released this week.
The Senate majority leader's travels were ranked seventh by PoliticalMoneyLine, a company based in Washington that tracks money in politics. He reimbursed companies $69,030 for flying on their planes from 2001 to 2005.
The market in India for outsourced clinical drug trials will hit $1.5 billion by 2010. Enticed by numbers like these, developing countries have been scrambling to catch Big Pharma's eye - India most aggressively of all.
One of the world's largest drug companies has been disciplined by the industry's UK watchdog after admitting that its staff entertained doctors to greyhound racing, lapdancing and Centre Court tickets at Wimbledon.
Americans are taking sleeping pills like never before, fueled by frenetic workdays that do not go gently into a great night's sleep, and lulled by a surge of consumer advertising that promises safe slumber with minimal side effects.
With enactment of a $453 billion defense spending bill at hand, opposition is growing over a provision granting pharmaceutical companies wide protection from lawsuits.
A Kazakh oil consortium has been accused of "mass poisoning" after 25 school children and four teachers passed out almost simultaneously at a school in Berezovka village in northwest Kazakhstan. The incident is the latest in a decade of allegations of pollution caused by the neighboring Karachaganak oil field.
When fakes of a GlaxoSmithKline anti-malarial drug turned up in Africa, authorities assumed the drug giant would want to know. Instead, they learned about a huge, evil trade in fake drugs -- and about an industry that doesn't want the truth to get out.
Susan Finston of the Institute for Policy Innovation, a conservative research group based in Texas, is just the sort of opinion maker coveted by the drug industry.
In an opinion article in The Financial Times on Oct. 25, she called for patent protection in poor countries for drugs and biotechnology products. In an article last month in the European edition of The Wall Street Journal, she called for efforts to block developing nations from violating patents on AIDS medicines and other drugs.
Multinational corporations are riding high on the trend toward globalization by taking advantage of India's educated work force and deep poverty to turn South Asia into the world's largest clinical-testing petri dish.